1. Academic Validation
  2. Imidazonaphthyridine systems (part 2): Functionalization of the phenyl ring linked to the pyridine pharmacophore and its replacement by a pyridinone ring produces intriguing differences in cytocidal activity

Imidazonaphthyridine systems (part 2): Functionalization of the phenyl ring linked to the pyridine pharmacophore and its replacement by a pyridinone ring produces intriguing differences in cytocidal activity

  • Eur J Med Chem. 2012 Jun:52:137-50. doi: 10.1016/j.ejmech.2012.03.011.
Nicolas Masurier 1 Eric Debiton Alicia Jacquemet Antoine Bussière Jean-Michel Chezal Anthony Ollivier Daté Tétégan Mounir Andaloussi Marie-Joseph Galmier Jacques Lacroix Damien Canitrot Jean-Claude Teulade René C Gaudreault Olivier Chavignon Emmanuel Moreau
Affiliations

Affiliation

  • 1 U990 INSERM, rue Montalembert, BP 184, 63000 Clermont-Ferrand, France.
Abstract

We recently discovered that five- and pseudo-five-fused-ring derivatives in an imidazonaphthyridine series were promising hit compounds for the development of new DNA-intercalators. In this study, novel (dihydro)imidazo[1,6] and [1,7]naphthyridi(no)nes were prepared including pseudo-pentacycles. All the compounds synthesized were screened against four tumor cell lines. Compounds 3(b-d) showed significant in vitro cytotoxicity, and DNA intercalation properties were demonstrated at 25 μM. Imidazonaphthyridinones exhibited no DNA binding affinity despite significant growth inhibition activity. Interestingly, when a pyridinone pharmacophore was linked to the imidazo[1,2-a]pyridine scaffold, the geometric orientation of the link had a strong impact on the growth inhibition activity. From these results we conclude that the moderate cytotoxicity observed for these compounds is independent of their DNA-binding and Topoisomerase inhibition activities.

Figures